Page last updated: 2024-10-24

celecoxib and Tinnitus

celecoxib has been researched along with Tinnitus in 1 studies

Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"High-dose celecoxib (2 g/kg), a selective COX-2 inhibitor, did not cause hearing loss or tinnitus in Sprague Dawley rats within 48 hours of administration."3.81Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats. ( Feng, Y; Li, B; Su, K; Xia, L; Yang, G; Yin, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, B1
Su, K1
Yang, G1
Feng, Y1
Xia, L1
Yin, S1

Other Studies

1 other study available for celecoxib and Tinnitus

ArticleYear
Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015, Volume: 152, Issue:6

    Topics: Animals; Auditory Threshold; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Re

2015